Heartsbreath Test for Heart Transplant Rejection

Status unconfirmed

Conditions studied: Heart Transplant Rejection

In brief

The purpose of this study is to demonstrate and validate a breath test for detection of biomarkers of heart transplant rejection (Grade 2R heart transplant).

Key facts

Study ID

NCT01397812

Run by

Menssana Research, Inc.

People needed

1200

Starts

2010-12-01

Expected to finish

2016-09-01

Last updated by the study team

2015-04-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject is willing and able to cooperate with study, understand the scope of the study, and gives signed informed consent to participate.
• Subject is the recipient of a heart transplant within the previous 12 months
• Subject is scheduled for a routine endomyocardial biopsy
• Subject is 18 years or older

You may not qualify if…

• Evidence of acute intercurrent disease other than rejection reaction

Where it is running

• Cedars-Sinai Medical Center — Beverly Hills, California, United States
• Stanford University School of Medicine — Stanford, California, United States
• Newark Beth Israel Medical Center — Newark, New Jersey, United States
• Columbia Presbyterian Medical Center — New York, New York, United States
• Hahnemann University Hospital and the Drexel University College of Medicine — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.